Bioventix (LON:BVXP) Shares Down 2.6%: What to Expect Next?

Bioventix PLC (LON:BVXP) experienced a decline of 2.6% in its share price during mid-day trading on Friday. The stock reached a low of GBX 3,450 ($43.54) and was last traded at GBX 3,456 ($43.62). In total, around 7,664 shares were exchanged, marking a significant increase of 31% from the average daily volume of 5,833 shares. The previous closing price was GBX 3,550 ($44.81).

Bioventix Stock Performance

The company boasts a market capitalization of £180.40 million, a price-to-earnings ratio of 2,120.25, and a beta of 0.35. The fifty-day moving average price stands at GBX 3,712.29 while the 200-day moving average price is at GBX 4,034.04.

Dividend Update

In a recent announcement, Bioventix declared a dividend that was paid out on Thursday, November 21st. Shareholders on record as of Thursday, November 7th received a dividend of GBX 87 ($1.10) per share, which is an increase from the previous dividend of $68.00. This change reflects a yield of 2.4%. However, it's important to note that Bioventix has an exceptionally high dividend payout ratio of 9,693.25%.

Insider Transactions

In other news regarding Bioventix, insider Bruce Hiscock purchased 24 shares on Friday, November 22nd. The shares were bought at an average price of GBX 3,822 ($48.24) each, making the total transaction amount to £917.28 ($1,157.74). Corporate insiders currently hold 8.02% of the company's shares.

About Bioventix

Bioventix PLC specializes in creating, manufacturing, and supplying sheep monoclonal antibodies (SMAs) for diagnostic applications globally. The company offers a diverse range of purified SMAs for various medical applications, which include thyroid, vitamin D, cardiac assessments, drug abuse tests, fertility analysis, oncology, among others. Additionally, Bioventix produces a specific ELISA kit (Pyrene HOP-G) to monitor human exposure to industrial pollutants.

Conclusion

This article aims to provide insights into the recent performance of Bioventix shares along with relevant updates on the company’s activities. Investors may want to consider these factors while making decisions about their investments.

Bioventix, Stocks, Dividend